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Incidence of cancer may vary within a country and over time
because of previous differences in exposure to risk factors or
interventions for early detection (screening). This study describes
time-space trends of incidence of common cancer sites across the
Netherlands during the period 1989–2003 and speculates on the
reasons for the observations. From the Netherlands Cancer Regis-
try, World standardized incidence rates per municipality were
smoothed calculating weighted averages for each 2 km by 2 km
grid of the population mid-points of neighbouring municipalities
and presented as map animations. Spatial relative changes in inci-
dence were estimated by comparing the periods 1989–1994 and
1998–2003. Complete time-space trends can be found as map ani-
mations on http://maps.ikcnet.nl. The incidence of cervical and
stomach cancer (for both sexes) decreased, being higher in the
cities than in the rural areas during all periods and contrasting
the trends in colorectal and breast cancer. The relative increase in
incidence of lung cancer among females was highest in the rural
north, but the incidence remained higher in the cities of the mid-
west Netherlands. For males, there was a marked decrease in lung
cancer incidence across the country since 1991. Incidence of mela-
noma increased, rates being twice as high in the coastal area than
in the cities. Prostate cancer maps largely replicated the known
history of PSA-testing in the Netherlands. Time-space cancer inci-
dence patterns gave insight into effects of changes in exposure to
risk determinants and early detection. The maps illustrate marked
potential for cancer prevention at the national and regional level.
' 2008 Wiley-Liss, Inc.
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The incidence of cancer is influenced by several factors and
therefore changes continuously. The incidence of several cancer
sites is known to be influenced by the intensity of exposure to risk
factors and many of these cancers might therefore be avoidable.1,2
Degree of urbanisation of the living environment, country of ori-
gin and socioeconomic status (SES) are indicators of exposure to
these risk factors.
Furthermore, the introduction of new diagnostic methods or
screening to recognise non-symptomatic cancers has led to an
increase in incidence of some cancer sites.
Timing and extent of changes in the aforementioned factors vary
over the country and thus can result in spatial differences in inci-
dence. Speculations on the reasons of the observed changes will be
clues into determinants (of the last 50 years), and avoidability of
cancer, taking effects of early detection into account. We produced
sets of maps and map animations (http://maps.ikcnet.nl) of changes
in cancer incidence across the Netherlands during 1989–2003.
Our aim was to give an overview of the changes in incidence in
the Netherlands since 1989, with some clues about the reasons for
the observations taking the exposure to known risk factors or
interventions for early detection (screening) into account. Since
the data considering these factors is not available and directly
linked to our data it was only possible to speculate about the rea-
sons for the observed results.
Material and methods
The Netherlands Cancer Registry (NCR) is population-based
and includes data on all newly diagnosed malignant cases since
1989. In 9 regions, all newly diagnosed malignancies are obtained
from the automated pathology archive (PALGA). Other sources
are the national patient hospital discharge registry, which accounts
for up to 8% of the cases,3 and radiotherapeutic and haematologi-
cal departments. The regional cancer registries submit their data
to the NCR, which is considered to be more than 95% complete,
incompleteness being more likely due to elderly and outpatients
with a clinical diagnosis only.4 Specially trained registration
clerks gather data concerning the patient (sex, date of birth),
tumour characteristics (localisation, histological type, stage, size),
and treatment characteristics. Narrow interpretation of the Euro-
pean privacy guideline of 1995 by Dutch privacy authorities and
legislation does not allow for routine use of death certificates.
From the NCR, World standardized incidence rates (WSR)
were calculated for the different cancer sites per municipality
(n 5 458). Cancer sites of interest were chosen based on known
substantial trends in incidence, changes in exposure to risk factors
and/or introduction, or alterations in screening interventions.
Maps of cancer incidence were made based on these rates. For the
cities with more than 100,000 inhabitants, the rates were presented
as circles on the maps; the radius of the circle indicates the size of
the population and the colour the WSR. Each step in colour scale
corresponds to a 1.1-fold increase in the WSR. The rates for the
remaining municipalities were smoothed to avoid chance varia-
tions.4 For each 2 km by 2 km grid, a weighted average was calcu-
lated of the WSR of the population mid-points of neighbouring
municipalities within 150 km to define the colour of that grid.
The rates were inversely related to the distance (weight was 50%
at 25 km) and directly weighted to the population size of the
municipality.
The 15-year period was split into 4 overlapping periods of 6
years, i.e., 1989–1994, 1992–1997, 1995–2000 and 1998–2003,
making the map animations more continuous. The relative
changes in WSR between the first and last period were also pre-
sented visually.
Results
In this article we present a selection of the cancer maps from a
larger series of maps. Complete time-space trends can be found as
map animations on http://maps.ikcnet.nl.
For the interpretation of these results, it is important to know
that of the more than 16 million inhabitants of the Netherlands
almost half of them are concentrated in the western, coastal region
(mid-west) in the large cities such as Amsterdam, Rotterdam, The
Hague and Utrecht (Fig. 1). The migrants (19% of the population
of the Netherlands in 2003), residing mainly in the larger cities
(Fig. 2), most often come from Morocco, Turkey, Surinam or the
Netherlands Antilles.
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All cancers
Incidence among males remained almost stable at a rate of
about 300 per 100,000 throughout the whole period. The incidence
remained slightly higher in most cities although a decrease was
seen in some large cities. Incidence among females increased
from 226 per 100,000 in 1989 to 257 in 2003. A higher incidence
was revealed in the larger cities and the mid-west compared to the
rest of the country, which was more prominent for females than
for males. There was a similar increase in incidence in females
across the whole of the Netherlands.
Gastrointestinal tract
The incidence of oesophageal cancer increased on an average
from 4.7 in 1989 to 8.0 per 100,000 males in 2003 and for females
from 1.5 to 2.5. Incidence was lowest in the south of the country,
both for males and females. There was a marked increase in inci-
dence in the south-east and in the northern city of Groningen for
males (Fig. 3).
Incidence of stomach cancer markedly decreased for males
from 16 per 100,000 in 1989 to 10 in 2003 and for females from
6.3 per 100,000 in 1989 to 4.2 in 2003. Still a slight urban domi-
nance in incidence remained. For males, the relative decrease in
incidence in the mid-Netherlands tended to be smaller in the cities
than in the rural areas. Still, the absolute decrease was larger in
these cities: e.g. the absolute decrease in the city of Utrecht was
2.0 and in the surrounding areas of Utrecht 1.2 per 100,000, both
yielding to a relative decrease of about 30%. For females, the
urban dominance increased over time due to almost no decrease in
many of the cities (Fig. 4).
FIGURE 1 – The Netherlands: inhabitants per 100,000 persons in
2003. Source: Statistics Netherlands.
FIGURE 2 – The Netherlands: percentage immigrants in 2003.
Source: Statistics Netherlands.
FIGURE 3 – Age-adjusted incidence of oesophageal cancer (World standard, per 100,000 person-years), 1998–2003 (left) and relative time-
space trend in incidence from the period 1989–1994 to 1998–2003, males.
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From 1989 to 2003 a small increase in incidence of colorectal
cancer was found from 35 to 40 among males and for females
from 27 to 29 per 100,000. For both males and females, both the
baseline incidence level and the relative increase in the rate tended
to be slightly higher in the east, but the spatial variation was gen-
erally small (Fig. 5).
Lung cancer
A lower incidence of lung cancer among males was observed in
1989–1994 in the urban, western part of the Netherlands, followed
by a decrease of 20–50% across the whole country, the difference
between cities and rural areas becoming smaller (Fig. 6). For
males, the overall incidence of lung cancer decreased from 74 per
100,000 in 1989 to 48 in 2003.
By contrast, the incidence of lung cancer among females
increased from 12 per 100,000 in 1989 to 22 in 2003. The inci-
dence was always highest in the largest cities, although its relative
increase appeared to be slower than in many rural areas (Fig. 7).
Melanoma
The incidence of skin melanoma was highest along the western
coast and lowest in several cities for both genders. It increased
from 7.5 per 100,000 in 1989 to 10.4 in 2003 for males and from
10.7 to 14.7 among females. The relative difference in rates
between west and east diminished as a result of a rapid increase in
incidence rates, especially in the south-east of the country. Against
the general strongly increasing trend, there was a decrease in some
large cities (Fig. 8).
Female genital organs
Among Dutch females, the incidence of breast cancer increased
from 73 per 100,000 in 1989 to 91 in 2003. The spatial differences
FIGURE 4 – Age-adjusted incidence of stomach cancer (World standard, per 100,000 person-years), 1989–1994 (left) and 1998–2003,
females.
FIGURE 5 – Relative time-space trend in incidence of colorectal cancer from the period 1989–1994 to 1998–2003, males (left) and females.
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and relative changes were small. In the cities in the south-east,
there was a tendency towards urban dominance over time.
Incidence of cervical cancer decreased from 7.2 per 100,000 in
1989 to 4.9 in 2003. Although the difference between urban and
rural areas diminished during the whole period, the incidence in
the cities generally remained higher than in rural surroundings
(Fig. 9). Rates were lowest in the eastern regions.
Incidence of ovarian cancer decreased from 11 per 100,000 in
1989 to 8.3 in 2003. Although the decrease was manifest in the
whole country, it was irregular, as was the urban–rural variation,
exhibiting a lower incidence in some cities than in their suburban
areas.
Male genital organs
The incidence of prostate cancer was generally lower in the
cities than in the surrounding areas. The spatial change was simi-
lar, with a possibly higher increase around major urological
centres like Nijmegen and Maastricht (Fig. 10). In the entire coun-
try, the incidence of prostate cancer increased from 39 per
100,000 in 1989 to 61 in 2003.
Incidence of testicular cancer increased from 3.9 per 100,000 in
1989 to 6.2 per 100,000 in 2003, remaining lowest in the cities of
Rotterdam and The Hague in the west and especially increasing
towards the north-east (Fig. 11).
Discussion
In this study we presented time-space variations in incidence of
frequently occurring and rapidly changing cancer rates as maps,
without administrative geographical boundaries. Spatial differen-
ces and time trends should generally be explained either by previ-
ous differences in exposure to risk factors and/or by early detec-
tion interventions. Logically, these trends do not necessarily fol-
low administrative borders and may vary within a given region.
The overall cancer incidence rate was higher among urban pop-
ulations as has been observed for many decades in numerous
countries.5,6 For males, the simultaneous decrease in the incidence
of e.g. lung cancer in 1993–2003 and the increase in incidence of
e.g. prostate cancer resulted in a relatively constant overall rate.
The slight decrease in incidence in some large cities could be due
to the well-documented increasing number of immigrants, with a
lower incidence of certain sites of cancer (e.g. in the breast and
colorectum) similar to the rates in their country of origin.7,8
Heavy drinking was fairly constant in the period 1989–2003,
when it became higher among males (20%) than females (5%).
There was also less drinking and smoking in the ‘‘Bible belt’’
going from the southwest to the middle of the Netherlands.7
Exposure to risk factors
Latency times of 20–50 years should be taken into account
when considering exposure to relevant risk factors to explain
time-space trends. For instance, the risk-increasing effect of smok-
ing starts to show up more than 20 years after its start, while the
first risk-decreasing effects of quitting (apparently on progression)
can be seen quickly.9 Males in the Netherlands, as in several other
countries in Europe, started to stop smoking in the 1960s, which
has resulted in a decrease in incidence of lung cancer among mid-
dle-aged males since the mid 1970s9–11 and later at older age. The
FIGURE 6 – Relative time-space trend in incidence of lung cancer from period 1989–1994 to 1998–2003, males (left) and females.
FIGURE 7 – Age-adjusted incidence of lung cancer (World standard,
per 100,000 person-years), 1998–2003, females.
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relative decrease in lung cancer incidence for males in the Nether-
lands from 90% in 1958 to 50% in 1980, decreasing further ever
since, was about the same across the country, suggesting a homog-
enous decline in smoking everywhere.12 Following the increased
smoking habits of Dutch women from 28% to 36% in 1980, rising
more in groups of lower SES and education,7,12 the increase in
incidence of lung cancer among females was most marked in the
urban, western part of the Netherlands and is clearly reflected in
the cancer maps about 30 years later.
Although the relative increase in incidence was highest in the
north-eastern rural part where female smoking increased in the
late 1960s, the level remained less than half of that in the larger
cities. Among males no such differences were found, implying
that a strong effect of factors such as air pollution can be
excluded.13,14 Effects of current stop-smoking campaigns are
likely to be seen at much shorter notice than of measures against
starting to smoke.
Smoking is a risk factor not only for lung cancer but also for sev-
eral other cancers, including oesophageal cancer. Given modest
changes in alcohol use, the more intense smoking habits among
women compared to men might partly explain the time-space trend
in oesophageal cancer being so similar to lung cancer. The overall
increase in the incidence of oesophageal cancer in the Netherlands
resulted mainly from an increase in the incidence of adenocarci-
noma from 1.3 per 100,000 in 1989 to 3.1 in 2003, representing
70% of all oesophageal cancers. Similar changes have been seen in
other countries as well.15,16 Other risk factors for oesophageal can-
cer are gastric reflux leading to Barrett’s oesophagus,18 obesity19,20
and alcohol consumption (mainly associated with squamous cell
carcinoma).21 Of these factors, obesity is more common in the east-
FIGURE 8 – Age-adjusted incidence of skin melanoma (World standard, per 100,000 person-years), 1998–2003 (left), and relative time-space
trend in incidence from period 1989–1994 to 1998–2003, females.
FIGURE 9 – Age-adjusted incidence of cervical cancer (World standard, per 100,000 person-years), 1989–1994 (left) and 1998–2003.
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ern parts of the Netherlands, where oesophageal cancer is yet rarest.
Heavy drinking was fairly constant in the period 1989–2003, when
it became higher among males (20%) than females (5%). There was
also less drinking and smoking in the Bible belt going from the
southwest to the middle of the Netherlands.7
The incidence of stomach cancer has decreased markedly dur-
ing the last decades following changes in dietary patterns and the
production, conservation and transportation of food, the large-
scale use of refrigerators, the decreasing prevalence of Helico-
bacter pylori, the lower use of salt, and the increased consumption
of fruit and vegetables. Although an inverse association between
level of education and stomach cancer, partly related to lifestyle,
has been found in the Netherlands and other countries,22 geo-
graphical differences in the incidence of stomach cancer were
modest, suggesting quite small variations in these lifestyle habits
within the country.
For colorectal cancer, the most important risk factors include di-
etary habits (e.g. excess calory intake and consumption of red
meat), lack of physical activity and a family history of colon can-
cer.23–25 The higher incidence in the eastern part of the Nether-
lands could reflect the influence of such habits from Germany.
Incidence of colorectal cancer in Germany appears to be 10–20%
higher than in the Netherlands.26 The higher (and markedly
increased) percentage of obesity in the eastern part of the country
may also play a role.27 Trends in incidence of colorectal cancer
also reflect the increasing proportion of migrants from low inci-
dence countries: incidence rates in the early 2000s were less than
6 per 100,000 in Morocco, 9 in Turkey and 10 in Surinam.26 The
FIGURE 10 – Age-adjusted incidence of prostate cancer (World standard, per 100,000 person-years), 1992–1997 (left), and relative time-space
trend in incidence from period 1989–1994 to 1998–2003.
FIGURE 11 – Age-adjusted incidence of testicular cancer (World standard, per 100,000 person-years), 1998–2003 (left), and relative time-
space trend in incidence from period 1989–1994 to 1998–2003.
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highest proportion of immigrants might also relate to the lower
incidence in the largest cities. There has been a shift from high to
low SES in overweight and unhealthy dietary habits resulting in
an increase in incidence of colorectal cancer in the lower SES e.g.
in Finland.28 Screening activities with faecal occult blood testing
have only been started in pilot studies recently and cannot affect
the incidence rates shown in the present article.
Obesity may have a moderate association with ovarian cancer.29
The relationship between fertility drugs and the cause of subfertil-
ity remains debatable.30 The relation with oestrogen replacement
therapy and an increased risk of ovarian cancer is more clear.31
The use of oral contraceptives has a protective effect on the risk of
ovarian cancer, which in the absence of other explanations can be
seen as the main reason for the decline described in this article.32
In the period 1995–1999, 40% of Dutch women used oral contra-
ceptives, which varied from 46% in the southern part (Noord-Bra-
bant) to 38% in the north (Groningen) and middle (Flevoland).7
The increasing age at last birth in the Netherlands27 could give
some protection, but there are no data on spatial variations in this
variable.33 Other risk factors such as previous breast cancer34 and
a family history of breast cancer35 will barely affect spatial trend.
The development of testicular cancer may be determined
largely by influences in very early life. Prenatal factors such as
low birth weight, older maternal age, low birth order as well as
cryptorchidism generally convey an increased risk.36,37 In the
Netherlands, the mean age of the mother at delivery of the first
child increased to 29 years in 2000.7 Other possible risk factors
are the carcinogenic effect of excess sex hormones and maternal
lifestyle (e.g. smoking during pregnancy).38 Would the increasing
incidence of lung cancer in females some decades ago has mir-
rored the increase in incidence of testicular cancer now? Several
studies have revealed that the geographical pattern of incidence is
more closely associated with residence at birth than with residence
at time of diagnosis, thus latency time and migration of young
male patients should be taken into account when interpreting geo-
graphical trends.39 Although in our study the most rapid increase
was in some cities—incidence doubled in 10 years—generally the
urban versus rural variations in incidence were irregular. As
everywhere the risk of testicular cancer was higher in the most
affluent areas compared to the most deprived areas, while there
was little difference between urban and rural small areas; this
argues against the influence of an environmental factor.40
The main risk factor for skin melanoma is intermittent exposure
to UV radiation, especially at a young age.41 For both males and
females, incidence was lowest in the southeast of the Netherlands
that hosts a lower proportion of people with fair skin.42 The inci-
dence was highest in the north-western coastal and lake areas
where aquatic sports are practised and there are 10% more sun
hours per year than in other parts of the country.43 In 1989 a
‘‘Freckle bus’’ campaign along the midwestern seacoast of the
Netherlands increased awareness of both the public as well as the
general practitioners across the country, partly explaining the
increase in incidence.44 In the 1960s and 1970s, sunny (subtrop-
ical) holidays, mountaineering and skiing became more popular,
primarily among higher SES classes who live outside the large
cities like Amsterdam, Eindhoven and Maastricht in whom inci-
dence of skin melanoma became higher. Increasing percentages of
allochthonous people with skin type 3–4, a natural protection
against UV radiation, might also be responsible for the lower inci-
dence and the more rapid decrease in the larger cities. In the north-
ern Netherlands (with more skin type 1–3) one tends to be more
willing to get a quick tan than in the south.45,46 The fact that inci-
dence of skin melanoma was rather low in areas with the highest
proportion of farmers is in line with the research finding that out-
door workers have a low risk of skin melanoma.47
Early detection interventions
Breast. An equivalent relative increase in incidence of breast
cancer was found in all regions of the Netherlands. Diagnostic ac-
tivity to reveal non-symptomatic breast cancer has been available
to the same extent all over the country since 1990. Introduction of
organised breast cancer screening started in 1974 in Utrecht in the
centre and in Nijmegen in eastern Netherlands for women at age
50–64 and 40–74 years, respectively. This may explain the highest
incidence rates found for this city. When the upper age limit
shifted from 69 to 74 years in 1998, Nijmegen was the first to
apply. The screening programme reached countrywide coverage
gradually in the period 1990–1996. Lower attendance rates in the
large cities in the west (about 15% lower than elsewhere), partly
related to the presence of migrants affected the incidence of breast
cancer negatively. Moreover, females from Turkey, Morocco and
Surinam had an incidence rate of about 22–30 per 100,000 in
2002, being much lower than the 91 per 100,000 in the Nether-
lands.26,48
Breast cancer tends to be more common in high social eco-
nomic classes, which can be linked to aspects of lifestyle.28,49 The
risk of breast cancer has increased with earlier menarche, older
age at first birth and lower number of children, later age at meno-
pause and postmenopausal hormonal therapy, which might be
counteracted by more physical activity, less obesity and alcohol
consumption,49,53 all relevant exposures in the last 25 years.
Cervical cancer. The national PAP-smear screening program
for cervical cancer, remodelled in 1996 (from a 3- to a 5-year
interval), focuses on detection of pre-malignant lesions and is
known to decrease the incidence.51 Cervical cancer incidence was
higher in areas with high population density, reflecting lifestyle
changes such as a lower age at first intercourse and multiple sexual
partners.52 In the Netherlands, highest risks were found for cervi-
cal cancer among women born in Morocco and Surinam,53 without
being known whether the prevalence of high risk HPV infections
among migrant women in the Netherlands is higher than among
the native women, but an increase in the incidence of sexually
transmitted diseases mainly among migrants was found in a study
in Utrecht in the Mid-Netherlands.54
Prostate cancer. Although the average increase from the 1990s
to the 2000s was similar all over the Netherlands, there were tem-
poral peaks in the rates, the most striking being the one seen in the
city of Rotterdam in southwest Netherlands in the period 1995–
1998. This peak can be explained by the pilot study for PSA-
screening which was started in 1994 in Rotterdam and surround-
ings (Fig. 12).55,56 Partly simultaneously, partly later, the inci-
dence (in fact the detection rate) of prostate cancer increased in
the remaining parts of the country because of the increasing use of
the PSA test as an opportunistic screening tool by urologists and
general practitioners. Generally, the lower incidence among males
FIGURE 12 – Incidence of prostate cancer in Rotterdam and in the
rest of the Netherlands (World standardized rates) from the period
1989–2003. [Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
2112 SIESLING ET AL.
in the cities reflects the difference in use of the PSA test, which is
typical for the higher social economic class males.57,58
Conclusion
Evident spatial patterns in incidence and variation in the rate of
change over time were revealed in the Netherlands for several can-
cer sites and they mostly complied with preceding changes in ex-
posure to risk determinants (related to SES) and causal risk factors
(smoking, UV light, dietary habits). Moreover, early detection/
screening interventions have clearly affected the incidence for
breast, cervical and prostate cancer as well as melanoma. All in
all, our study also provides evidence for a large potential for pre-
vention of cancer. Knowledge of regional variation in cancer inci-
dence can support the planning of health care services on a re-
gional basis.
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